Condition: Prostate Carcinoma · Sponsor: University of Washington
This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.
This description comes directly from the study's public registry record.
Study Team Coordinator · 206-210-4040 · patrol@uw.edu
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Northwestern | Chicago, Illinois, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| OHSU Knight Cancer Institute | Portland, Oregon, United States | Recruiting |
| University of Pennsylvania/Abramson Cancer Center | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Texas Health Science Center at San Antonio | San Antonio, Texas, United States | Terminated |
| Fred Hutch/University of Washington Cancer Consortium | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04472338